WallStreetZenWallStreetZen

NASDAQ: CME
Cme Group Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Cme Group revenue was $6.13B for the trailing 12 months ending Dec 31, 2024, with 9.2% growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.5B, down 3.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CME annual revenue was $6.1B, with 9.9% growth year-over-year.

CME past revenue growth

How has CME's revenue growth performed historically?

Company
9.88%
Industry
22.13%
Market
20.68%
CME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CME's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CME's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CME revenue history

Current Revenue
$6.1B
Current Earnings
$3.5B
Current Profit Margin
56.8%
CME's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when CME announces revenue.

CME Revenue History By Year

CME Yearly RevenueCME RevenueCME ChangeCME Revenue Growth
2024-12-31$6.13B$551.20M+9.88%
2023-12-31$5.58B$559.50M+11.15%
2022-12-31$5.02B$329.70M+7.03%
2021-12-31$4.69B-$193.90M-3.97%
2020-12-31$4.88B$15.60M+0.32%
2019-12-31$4.87B$558.60M+12.96%
2018-12-31$4.31B$664.70M+18.24%
2017-12-31$3.64B$49.50M+1.38%
2016-12-31$3.60B$268.40M+8.07%
2015-12-31$3.33B$214.30M+6.89%
2014-12-31$3.11B$176.20M+6.00%
2013-12-31$2.94B$21.70M+0.74%
2012-12-31$2.91B-$366.00M-11.16%
2011-12-31$3.28B$276.90M+9.22%
2010-12-31$3.00B$390.90M+14.96%
2009-12-31$2.61B$51.80M+2.02%
2008-12-31$2.56B$804.90M+45.83%
2007-12-31$1.76B$666.15M+61.12%
2006-12-31$1.09B$200.18M+22.50%
2005-12-31$889.77M$168.21M+23.31%
2004-12-31$721.55M$185.51M+34.61%
2003-12-31$536.04M$82.86M+18.29%
2002-12-31$453.18M$66.02M+17.05%
2001-12-31$387.15M$160.60M+70.89%
2000-12-31$226.55M$15.95M+7.57%
1999-12-31$210.60MN/AN/A

1 of 2

Cme Group Revenue FAQ

What was CME's revenue last quarter?

On Invalid Date, Cme Group (NASDAQ: CME) reported Q4 2024 revenue of $1.53 billion up 5.98% year over year. In the same quarter last year, Cme Group's revenue was $1.44 billion.

What was Cme Group's revenue in 2024?

Cme Group's annual revenue for the twelve months ending Dec 31, 2024 was $6.13 billion, a 9.88% increase year over year.

How much does Cme Group make in a day?

Based on Cme Group annual revenue for the past five years, CME makes an average of $14,411,890.41 per day.

What was Cme Group's annual revenue growth in the past year?

As of Q2 2025, Cme Group's revenue has grown 9.88% year over year. This is 12.25 percentage points lower than the US Financial Data & Stock Exchanges industry revenue growth rate of 22.13%. Cme Group's revenue in the past year totaled $6.13 billion.

How much does Cme Group make in a year?

Cme Group's revenue by year for the past five years is:
  • Cme Group's revenue for the twelve months ending Dec 31, 2024 was $6.13 billion, a 9.88% increase year over year.
  • Cme Group's annual revenue for Dec 31, 2023 was $5.58 billion, a 11.15% increase from 2022.
  • Cme Group's annual revenue for 2022 was $5.02 billion, a 7.03% increase from 2021.
  • Cme Group's annual revenue for 2021 was $4.69 billion, a 3.97% decrease from 2020.
  • Cme Group's annual revenue for 2020 was $4.88 billion, a 0.32% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.